October 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Hair loss significantly affects emotional and social well-being.
October 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Hair loss significantly affects emotional and social well-being.
3 citations
,
November 2021 in “Frontiers in medicine” Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.
17 citations
,
May 2007 in “Forensic Science Medicine and Pathology” Clozapine levels in hair reflect dosage and bind more to pigmented hair.
16 citations
,
February 2009 in “Clinical neurology and neurosurgery” Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.
13 citations
,
July 2022 in “International Journal of Environmental Research and Public Health” Males had more severe COVID-19 symptoms, but their risk of death was only slightly higher than females.
1 citations
,
February 2023 in “Journal of Athletic Training” Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.
1 citations
,
January 2022 in “Journal of Cancer Therapy” Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.
Acupuncture helped a man with long-term hair loss regrow his hair.
Acupuncture may effectively treat long-standing alopecia areata.
January 2026 in “Journal of Aesthetic Medicine” Aesthetic care should align physical changes with mental well-being using a comprehensive, multidisciplinary approach.
January 2026 in “Behavioral Sciences” Negative illness perceptions increase emotional distress, worsening OCD symptoms in alopecia areata patients.
August 2024 in “Journal of Cosmetic Dermatology” Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.
November 2020 in “Universal Journal of Pharmaceutical Research” Tacrolimus is a better option than cyclosporine due to fewer side effects.
3 citations
,
October 2024 in “Experimental Dermatology” Higher CRHR1 levels in AA patients lead to increased inflammation.
August 2025 in “International Journal of Clinical Dermatology” A new skin cancer can develop where shingles once occurred.
October 2023 in “IP Indian Journal of Clinical and Experimental Dermatology” The luliconazole shampoo effectively reduces symptoms of seborrheic dermatitis and is well-tolerated.
August 2025 in “Frontiers in Nutrition” Leucine levels may affect hair loss after bariatric surgery.
June 2023 in “BMC Pharmacology and Toxicology” The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.
61 citations
,
April 2021 in “Frontiers in Medicine” Hidradenitis suppurativa severely impacts quality of life, especially with severe symptoms and certain comorbidities, and current treatments don't significantly improve it.
34 citations
,
October 2011 in “Journal of the American Academy of Dermatology” Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.
7 citations
,
March 2023 in “Pharmacy” Pharmacist-led care significantly improved post-COVID symptoms.
4 citations
,
November 2022 in “BMC Women s Health” HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.
2 citations
,
July 2024 in “Journal of Clinical Medicine” Telemedicine is effective for managing alopecia areata follow-ups.
2 citations
,
April 2024 in “AIDS Research and Therapy” Syphilis can cause hair loss and skin changes in HIV-positive patients, and proper treatment can resolve these symptoms.
1 citations
,
November 2024 in “AME Medical Journal” Vitamin C deficiency can persist in high-risk patients despite supplementation.
November 2025 in “BMC Urology” Larger prostate size, longer surgery, and smoking increase risks, while finasteride and experienced surgeons reduce them during prostate surgery.
September 2025 in “Asian journal of pediatric dermatology.” Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.
July 2025 in “Skin Health and Disease” PRP is a good alternative or addition to minoxidil for treating hair loss.
Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.